hydration effects glp-1 receptor agonists weight loss Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind of Frontiers | GLP-1 Receptor Agonists:
Pay in 4 interest-free payments of $7.01 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
![hydration effects glp-1 receptor agonists weight loss Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind of Frontiers | GLP-1 Receptor Agonists:](https://www.frontiersin.org/api/ipx/w=1200&f=png/https://www.frontiersin.org/files/Articles/721135/fendo-12-721135-HTML/image_m/fendo-12-721135-g001.jpg)
![hydration effects glp-1 receptor agonists weight loss Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind of Frontiers | GLP-1 Receptor Agonists:](https://www.mdpi.com/biomolecules/biomolecules-15-00408/article_deploy/html/images/biomolecules-15-00408-g001-550.jpg)
![hydration effects glp-1 receptor agonists weight loss Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind of Frontiers | GLP-1 Receptor Agonists:](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs12170-025-00761-0/MediaObjects/12170_2025_761_Fig1_HTML.png)
![hydration effects glp-1 receptor agonists weight loss Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind of Frontiers | GLP-1 Receptor Agonists:](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41392-024-01931-z/MediaObjects/41392_2024_1931_Fig4_HTML.png)





















